06:03:47 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



T:CRDL - CARDIOL THERAPEUTICS INC. CL 'A' - http://cardiolrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRDL - T  1.02.77·2.784.92.77+0.062.2129.93314522.77  2.83  2.692.94  0.74May 06Apr 1715 min RT 2¢
TSX - T1.02.77·2.784.92.77+0.062.274.51902442.77  2.83  2.692.94  0.74May 0615 min
NEO ATS - U 2.74+0.031.15.614252.75  2.81  2.69May 0615 min
Alpha - A 2.76+0.051.84.511182.73  2.81  2.71May 0615 min
Omega - O 2.77+0.062.23.59202.71  2.77  2.71May 0615 min
Pure - P 2.73+0.020.71.12132.80  2.81  2.71May 0615 min
Chi-X - X 2.77+0.062.210.426432.77  2.81  2.71May 0615 min
CX2 - H 2.77+0.062.229.076702.73  2.81  2.71May 0615 min
CXD - D 2.710.103    May 0315 min
TriAct - M 2.710.7112    Sep 11-2015 min
CS2 - S 2.73+0.020.70.4142.73  2.81  2.73May 0615 min

Recent Trades - Last 10 of 452
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-17 13:49C:CRDL2.415Warrants ExpireCardiol Therapeutics warrants to expire May 13
2024-04-02 09:26C:CRDL2.58News ReleaseCardiol Therapeutics recaps 2023 operations
2024-04-01 19:04C:CRDL2.58SEDAR Annual ReportSEDAR Annual Report
2024-04-01 18:57C:CRDL2.58SEDAR MD & ASEDAR MD & A
2024-04-01 18:45C:CRDL2.58SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-21 11:23C:CRDL2.25News ReleaseCardiol completes patient enrolment for CardiolRx study
2024-02-15 09:28C:CRDL1.42News ReleaseCardiol receives orphan drug designation for CardiolRx
2024-01-24 11:08C:CRDL1.52News ReleaseCardiol regains Nasdaq listing standard compliance
2024-01-09 11:35C:CRDL1.36News ReleaseCardiol enrolls over 50% of patients in Archer study
2023-12-05 11:11C:CRDL1.29News ReleaseCardiol adds Mass. General Hospital to CardiolRx study
2023-11-16 09:18C:CRDL1.14News ReleaseCardiol presents CardiolRx study results at MPD2023
2023-11-14 16:45C:CRDL1.19SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 16:41C:CRDL1.19SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-01 10:27C:CRDL1.17News ReleaseCardiol enrolls over 50% of patients in CardiolRx study
2023-10-20 17:16C:CRDL0.94News ReleaseCardiol's share price sinks below Nasdaq $1 (U.S.) min.
2023-10-10 10:00C:CRDL1.18News ReleaseCardiol's CRD-38 study shows cardioprotective effects
2023-09-19 10:39C:CRDL1.31News ReleaseCardiol expects full enrolment in Archer phase 2 trial
2023-08-10 17:07C:CRDL1.31SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-08 12:53C:CRDL1.60News ReleaseCardiol Therapeutics meets Nasdaq minimum bid price
2023-06-29 16:13C:CRDL1.06News ReleaseCardiol shareholders elect eight directors at AGM